Alternative Splicing (AS) Provides an Alternative Mechanism for Regulating GLIS3 Expression and Activity
Cells · 2025
DOI: 10.3390/cells14231912 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von David W Scoville und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cell Biology Group, Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health…. Hauptthemen laut MEDLINE: Alternative Splicing, Repressor Proteins, Trans-Activators, Gene Expression Regulation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, Intramural Research Program of the NIEHS.
Abstract (Originalsprache)
The Krüppel-like transcription factor GLIS3 plays an important regulatory role in the development of various tissues, both in mice and humans. Loss-of-function mutations in GLIS3 are implicated in several pathologies, including polycystic kidney disease, diabetes, and hypothyroidism. Previous studies have reported that the mouse Glis3 gene generates a 7524 bp mRNA encoding a 935 amino acid (aa) protein, with a homologous human protein of 930 aa. Here, we identify a shorter mouse mRNA lacking the third exon, producing a shorter 659 aa GLIS3 protein. This shorter transcript is expressed at a higher level than the longer transcript in all mouse tissues tested and produces a protein that is more stable and exhibits a greater transactivation potential. This suggests that the 276 aa N-terminus in the longer mouse GLIS3 protein encompasses important regulatory domain(s). Mass spectrometry identified several phosphorylation sites that may contribute to the post-translational regulation of GLIS3 activity and function and several known members of co-activator and co-repressor complexes, consistent with the concept that GLIS3 can act both as a transcriptional repressor and activator. These data offer important insights into how GLIS3 activity is regulated and offer potential mechanisms for its control during tissue development and disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cell Biology Group, Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC 27709, USA.
- Integrative Bioinformatics Support Group, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC 27709, USA.
- Mass Spectrometry Research and Support Group, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, NC 27709, USA.
ORCID-Profile: David W Scoville, Sara A Grimm, Anton M Jetten
Förderung
- Intramural NIH HHS
- Intramural Research Program of the NIEHS
Zitieren
APA
Scoville, D. W., Grimm, S. A., Williams, J. G., & Jetten, A. M. (2025). Alternative Splicing (AS) Provides an Alternative Mechanism for Regulating GLIS3 Expression and Activity. Cells. https://doi.org/10.3390/cells14231912
Vancouver
Scoville DW, Grimm SA, Williams JG, Jetten AM. Alternative Splicing (AS) Provides an Alternative Mechanism for Regulating GLIS3 Expression and Activity. Cells. 2025. doi:10.3390/cells14231912
BibTeX
@article{Scoville2025,
author = {Scoville, David W and Grimm, Sara A and Williams, Jason G and Jetten, Anton M},
title = {Alternative Splicing (AS) Provides an Alternative Mechanism for Regulating GLIS3 Expression and Activity},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14231912}
}
EUVIMED